178 related articles for article (PubMed ID: 27162011)
1. 1-(5-Carboxyindazol-1-yl)propan-2-ones as dual inhibitors of cytosolic phospholipase A
Althaus J; Hake T; Hanekamp W; Lehr M
J Enzyme Inhib Med Chem; 2016; 31(sup1):131-140. PubMed ID: 27162011
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies on 1-heteroaryl-3-phenoxypropan-2-ones acting as inhibitors of cytosolic phospholipase A2α and fatty acid amide hydrolase: replacement of the activated ketone group by other serine traps.
Sundermann T; Hanekamp W; Lehr M
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):653-63. PubMed ID: 26153239
[TBL] [Abstract][Full Text] [Related]
3. 1-(3-biaryloxy-2-oxopropyl)indole-5-carboxylic acids and related compounds as dual inhibitors of human cytosolic phospholipase A2α and fatty acid amide hydrolase.
Zahov S; Drews A; Hess M; Schulze Elfringhoff A; Lehr M
ChemMedChem; 2011 Mar; 6(3):544-9. PubMed ID: 21259444
[TBL] [Abstract][Full Text] [Related]
4. 1-(5-Carboxy- and 5-carbamoylindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: bioisosteric replacement of the carboxylic acid and carboxamide moiety.
Hess M; Schulze Elfringhoff A; Lehr M
Bioorg Med Chem; 2007 Apr; 15(8):2883-91. PubMed ID: 17320401
[TBL] [Abstract][Full Text] [Related]
5. 1-Heteroaryl-3-phenoxypropan-2-ones as inhibitors of cytosolic phospholipase A₂α and fatty acid amide hydrolase: Effect of the replacement of the ether oxygen with sulfur and nitrogen moieties on enzyme inhibition and metabolic stability.
Sundermann T; Fabian J; Hanekamp W; Lehr M
Bioorg Med Chem; 2015 May; 23(10):2579-92. PubMed ID: 25862211
[TBL] [Abstract][Full Text] [Related]
6. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
Forster L; Ludwig J; Kaptur M; Bovens S; Elfringhoff AS; Holtfrerich A; Lehr M
Bioorg Med Chem; 2010 Jan; 18(2):945-52. PubMed ID: 20005725
[TBL] [Abstract][Full Text] [Related]
7. 1-Heteroarylpropan-2-ones as inhibitors of fatty acid amide hydrolase: Studies on structure-activity relationships and metabolic stability.
Zahov S; Garzinsky D; Hanekamp W; Lehr M
Bioorg Med Chem; 2017 Feb; 25(3):825-837. PubMed ID: 27989417
[TBL] [Abstract][Full Text] [Related]
8. 1-(5-Carboxyindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis and properties of bioisosteric benzimidazole, benzotriazole and indazole analogues.
Bovens S; Kaptur M; Elfringhoff AS; Lehr M
Bioorg Med Chem Lett; 2009 Apr; 19(8):2107-11. PubMed ID: 19327988
[TBL] [Abstract][Full Text] [Related]
9. 1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis, biological activity, metabolic stability, and solubility.
Fritsche A; Elfringhoff AS; Fabian J; Lehr M
Bioorg Med Chem; 2008 Apr; 16(7):3489-500. PubMed ID: 18321717
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha.
Ludwig J; Bovens S; Brauch C; Elfringhoff AS; Lehr M
J Med Chem; 2006 Apr; 49(8):2611-20. PubMed ID: 16610804
[TBL] [Abstract][Full Text] [Related]
11. Convergent and enantioselective syntheses of cytosolic phospholipase A(2)α inhibiting N-(1-indazol-1-ylpropan-2-yl)carbamates.
Sundermann T; Arnsmann M; Schwarzkopf J; Hanekamp W; Lehr M
Org Biomol Chem; 2014 Jun; 12(23):4021-30. PubMed ID: 24817191
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies on 1-(2-oxopropyl)indole-5-carboxylic acids acting as inhibitors of cytosolic phospholipase A
Arnsmann M; Hanekamp W; Elfringhoff AS; Lehr M
Eur J Med Chem; 2017 Jan; 125():1107-1114. PubMed ID: 27810597
[TBL] [Abstract][Full Text] [Related]
13. 1-(5-Carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2α: effect of substituents in position 3 of the indole scaffold on inhibitory potency, metabolic stability, solubility, and bioavailability.
Bovens S; Schulze Elfringhoff A; Kaptur M; Reinhardt D; Schäfers M; Lehr M
J Med Chem; 2010 Dec; 53(23):8298-308. PubMed ID: 21067218
[TBL] [Abstract][Full Text] [Related]
14. Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors.
Deplano A; Cipriano M; Moraca F; Novellino E; Catalanotti B; Fowler CJ; Onnis V
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):562-576. PubMed ID: 30688118
[TBL] [Abstract][Full Text] [Related]
15. N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors.
Sunduru N; Svensson M; Cipriano M; Marwaha S; Andersson CD; Svensson R; Fowler CJ; Elofsson M
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):513-521. PubMed ID: 28114819
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of 3-(1-Aryl-1H-indol-5-yl)propanoic acids as new indole-based cytosolic phospholipase A2α inhibitors.
Tomoo T; Nakatsuka T; Katayama T; Hayashi Y; Fujieda Y; Terakawa M; Nagahira K
J Med Chem; 2014 Sep; 57(17):7244-62. PubMed ID: 25102418
[TBL] [Abstract][Full Text] [Related]
17. Investigations on the metabolic stability of cytosolic phospholipase A2α inhibitors with 1-indolylpropan-2-one structure.
Fabian J; Hanekamp W; Thomas MH; Olivier JL; Lehr M
Chem Biol Interact; 2013 Nov; 206(2):356-63. PubMed ID: 24120545
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 3-pyrrol-3-yl-3H-isobenzofuran-1-ones as inhibitors of human cytosolic phospholipase A2alpha.
Hess M; Schulze Elfringhoff A; Lehr M
J Enzyme Inhib Med Chem; 2008 Dec; 23(6):946-57. PubMed ID: 18608744
[TBL] [Abstract][Full Text] [Related]
19. Targeting Cytosolic Phospholipase A2α for Novel Anti-Inflammatory Agents.
Soubhye J; van Antwerpen P; Dufrasne F
Curr Med Chem; 2018; 25(21):2418-2447. PubMed ID: 29345571
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activity.
Roughley SD; Browne H; Macias AT; Benwell K; Brooks T; D'Alessandro J; Daniels Z; Dugdale S; Francis G; Gibbons B; Hart T; Haymes T; Kennett G; Lightowler S; Matassova N; Mansell H; Merrett A; Misra A; Padfield A; Parsons R; Pratt R; Robertson A; Simmonite H; Tan K; Walls SB; Wong M
Bioorg Med Chem Lett; 2012 Jan; 22(2):901-6. PubMed ID: 22209458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
